Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update.
Mellar P DavisDavid HuiAndrew DaviesCarla RipamontiAndreia CapelaGiulia DeFeoEgidio Del FabbroEduardo BrueraPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
The panel recommends octreotide in non-operable MBO. Randomized trials are needed to clarify ranitidine and antiemetic choices.